Alternative CD44 splicing in intestinal stem cells and tumorigenesis

W Guo1, P S Frenette1

  • 1Department of Cell Biology, Albert Einstein College of Medicine, Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine, Bronx, NY, USA.

Oncogene
|July 9, 2013
PubMed
Summary

A specific CD44 variant in intestinal stem cells drives tumor formation. Standard CD44, common in other cells, does not promote this tumorigenesis, revealing isoform-specific roles in cancer development.